Cardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities
Journal of Cardiovascular Development and Disease · 21.03.2024 · 11 (3) · 95
DOI: 10.3390/jcdd11030095 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 21.03.2024. Verfasst von Moaz A Kamel und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85054, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiac allograft vasculopathy (CAV) is a distinct form of coronary artery disease that represents a major cause of death beyond the first year after heart transplantation. The pathophysiology of CAV is still not completely elucidated; it involves progressive circumferential wall thickening of both the epicardial and intramyocardial coronary arteries. Coronary angiography is still considered the gold-standard test for the diagnosis of CAV, and intravascular ultrasound (IVUS) can detect early intimal thickening with improved sensitivity. However, these tests are invasive and are unable to visualize and evaluate coronary microcirculation. Increasing evidence for non-invasive surveillance techniques assessing both epicardial and microvascular components of CAV may help improve early detection. These include computed tomography coronary angiography (CTCA), single-photon emission computed tomography (SPECT), positron emission tomography (PET), and vasodilator stress myocardial contrast echocardiography perfusion imaging. This review summarizes the current state of diagnostic modalities and their utility and prognostic value for CAV and also evaluates emerging tools that may improve the early detection of this complex disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85054, USA.
- Department of Cardiothoracic Surgery, Mayo Clinic, Phoenix, AZ 85054, USA.
- Department of Radiology, Mayo Clinic, Phoenix, AZ 85054, USA.
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA.
ORCID-Profile: Isabel G Scalia, Amro T Badr, Juan M Farina, Milagros Pereyra, Mohammed Tiseer Abbas, Ahmed K Mahmoud, Julie L Rosenthal, Lisa M Lemond, Timothy Barry, Reza Arsanjani
Zitieren
APA
Kamel, M. A., Scalia, I. G., Badr, A. T., Baba Ali, N., Farina, J. M., Pereyra, M., Abbas, M. T., Mahmoud, A. K., Scott, R. L., Steidley, D. E., Rosenthal, J. L., Lemond, L. M., Sell-Dottin, K. A., Hardaway, B. W., Barry, T., Yang, M., Chao, C. J., Jokerst, C. E., Ayoub, C., & Arsanjani, R. (2024). Cardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities. Journal of Cardiovascular Development and Disease, 11(3), 95. https://doi.org/10.3390/jcdd11030095
Vancouver
Kamel MA, Scalia IG, Badr AT, Baba Ali N, Farina JM, Pereyra M, et al. Cardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities. Journal of Cardiovascular Development and Disease. 2024;11(3):95. doi:10.3390/jcdd11030095
BibTeX
@article{Kamel2024,
author = {Kamel, Moaz A and Scalia, Isabel G and Badr, Amro T and Baba Ali, Nima and Farina, Juan M and Pereyra, Milagros and Abbas, Mohammed Tiseer and Mahmoud, Ahmed K and Scott, Robert L and Steidley, David E and Rosenthal, Julie L and Lemond, Lisa M and Sell-Dottin, Kristen A and Hardaway, Brian W and Barry, Timothy and Yang, Ming and Chao, Chieh-Ju and Jokerst, Clinton E and Ayoub, Chadi and Arsanjani, Reza},
title = {Cardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities},
journal = {Journal of Cardiovascular Development and Disease},
year = {2024},
volume = {11},
number = {3},
pages = {95},
doi = {10.3390/jcdd11030095}
}
EUVIMED